Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020672 (
hypothermia
)
17,327
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have examined the effect of mildly hypothermic temperatures (22-32 degrees) on the cytotoxicity of Adriamycin, cis-diamminedichloroplatinum, bleomycin, and 1,3-bis(2-chloroethyl)-1-nitrosourea in Chinese hamster ovary cells in vitro. Over a dose range of Adriamycin, cell killing at 30 degrees was reduced by 1 to 3 orders of magnitude as compared to that at 37 degrees. cis-
Diamminedichloroplatinum
was also less cytotoxic at 30 degrees (0.4 to 1.2 orders of magnitude) than at 37 degrees. For bleomycin and 1,3-bis(2-chloroethyl)-1-nitrosourea, the reduction in cytotoxicity at 30 degrees in comparison to 37 degrees was less marked. All drugs were more toxic at 42.4-43 degrees than at 37 degrees. Precooling of cells for 2 hr at 30 degrees did not alter the cell killing caused by these drugs at elevated temperatures. These results suggest that a more selective anticancer effect might result if some chemotherapeutic drugs were administered during whole-body
hypothermia
and regional-local hyperthermia of tumor masses.
...
PMID:Temperature dependence of adriamycin, cis-diamminedichloroplatinum, bleomycin, and 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity in vitro. 618 47